The FDA this morning recommended halting distribution of the Johnson & Johnson vaccine at federal sites out of an abundance of caution due to a rare blood clotting disorder observed in six out of more than 6 million vaccinated people.
The Pennsylvania Department of Health has paused administering doses of the Johnson & Johnson/Janssen vaccine until at least April 20. Pending appointments in Pennsylvania will either be canceled immediately or rescheduled using Pfizer or Moderna vaccine.
The University will not distribute any further Johnson & Johnson vaccine until the CDC and FDA recommend the pause be lifted. In the interim, the University will distribute available first and second doses of the Pfizer and Moderna vaccines—and continue to emphasize key reasons to get vaccinated as soon as you have the opportunity.
As virologists and infection prevention experts, we want to reassure patients that all COVID-19 vaccines are being constantly monitored for safety and effectiveness, and this latest announcement shows the process is working.
Stay well and stay safe. Thank you for your partnership and patience.
Sincerely,
COVID-19 Medical Response Office